Dr. Nadeem R. Abu-Rustum, MD

Dr. Abu-Rustum practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Abu-Rustum's NPI, 1164407540, was assigned on December 8, 2005. Dr. Abu-Rustum graduated from American University of Beirut Faculty of Medicine in 1990. Dr. Abu-Rustum holds New York license 220080.

Dr. Abu-Rustum's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Abu-Rustum's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery. Dmand AI also links Dr. Abu-Rustum to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abu-Rustum practices, 2 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Abu-Rustum's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Abu-Rustum is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Abu-Rustum's licenses on file in 6 states: New York, Delaware, California, New Jersey, Maryland and Illinois.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Abu-Rustum treats.

CMS data shows 42 Medicare services from Dr. Abu-Rustum across 2 procedure codes in 2024, all of them office visits, for 62 Medicare patients. Medicare paid $5,288 for them. Every service was in an office.

CMS counts 62 Medicare patients who saw Dr. Abu-Rustum in 2024. The largest group is 65 to 74, with 33 patients. 73% of them have high cholesterol, and 63% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abu-Rustum's median patient age at 64, with 96% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Abu-Rustum for performance year 2024, reported as part of a group. Dr. Abu-Rustum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of removal of the uterus by Dr. Abu-Rustum, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 481 papers to Dr. Abu-Rustum, published from 2005 to 2025. 2024 was the busiest year, with 36. The most frequent topics are Endometrial Neoplasms, Ovarian Neoplasms and Uterine Cervical Neoplasms. Dr. Abu-Rustum has published most often in Gynecol Oncol. Dr. Abu-Rustum's most frequent co-authors are Dennis S. Chi, MD, Yukio Sonoda, MD and Mario Mendes Leitao, MD.

Dmand AI links Dr. Abu-Rustum to 10 clinical trials. 5 are still active or recruiting. Conditions studied include Endometrial Neoplasms, Uterine Cervical Neoplasms and Carcinoma, Endometrioid. Memorial Sloan Kettering Cancer Center sponsors the most, 8.

CMS Open Payments shows 27 general payments to Dr. Abu-Rustum from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Novadaq Technologies Inc. paid the most, $1,737. It also lists 5 research payments totaling $46,270 in 2016.

Dmand AI lists 7 awards for Dr. Abu-Rustum, most recently America's Top Doctors in 2014.

Dr. Abu-Rustum graduated from American University of Beirut Faculty of Medicine in 1990. Dr. Abu-Rustum is a member of American College of Obstetricians and Gynecologists, ACS and SLS.

Dr. Abu-Rustum is in network with 14 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.